Her surgery was delayed and after appropriate expert consultation and bone marrow examination her anaemia was treated with blood transfusions and her persistent neutropenia with G-CSF, making this also a Grade 3 adverse event according to CTCAE criteria. The gene discussed is CSF3; the disease is neutropenia.